Fasa Registry on Diabetes mellitus (FaRD): Feasibility Study and Pilot Phase Results

Abstract

BackgroundDiabetes mellitus (DM) is the most common chronic diseases. This disease is the main risk factor of fetal diseases such as myocardial infarction and stroke. There is no cure for DM, and an effective strategy must control it. Every attempt to control DM and patient outcomes require a surveillance system to consider the efficacy and safety measures. Fasa Registry on Diabetes mellitus (FaRD) is the first population-based registry for DM in Iran targeted to provide a meticulous description of social, mental health, clinical, and laboratory values of patients, to consider the management patterns of these patients, to discover the degree of adherence to the recommendations.Methodsthe diagnosis of diabetes (Type I and II) characterized by the level of plasma glucose. The pregnant women were excluded. Three registrar nurses collected data on demographics, physical exams, past medical history, medication history, and laboratory findings. Resultsthe pilot phase included the first 381 patients, 257 (67.5%) were women, and 124 (32.5%) were men. With a mean age of 57.54 ± 12.12years among subjects, the 347 (94.5%) of them had DM type 2, and 20 (5.4%) of them had type 1. ConclusionBased on our results, the characteristics of patients suffering DM do not afford their medical cost, so the majority of them were not adherence to the practice guidelines.The achievement of FaRD helps physicians and patients to better controlling the DM.The finding of this pilot study shows the FaRD is feasible, and it will make a comprehensive population-based registry for DM in the region.